Literature DB >> 2152030

Regulation of the skeletal sarcoplasmic reticulum Ca2+ pump by phospholamban in reconstituted phospholipid vesicles.

G Szymańska1, H W Kim, J Cuppoletti, E G Kranias.   

Abstract

Phospholamban is the regulator of the Ca(2+)-ATPase in cardiac sarcoplasmic reticulum (SR). The mechanism of regulation appears to involve inhibition by dephosphorylated phospholamban, and phosphorylation may relieve this inhibition. Fast-twitch skeletal muscle SR does not contain phospholamban, and it is not known whether the Ca(2+)-ATPase isoform from this muscle may be also subject to regulation by phospholamban in a similar manner as the cardiac isoform. To determine this we reconstituted the skeletal isoform of the SR Ca(2+)-ATPase with phospholamban in phosphatidylcholine proteoliposomes. Inclusion of phospholamban was associated with significant inhibition of the initial rates of Ca2+ uptake at pCa 6.0, and phosphorylation of phospholamban by the catalytic subunit of cAMP-dependent protein kinase reversed the inhibitory effects on the Ca2+ pump. Similar effects of phospholamban were also observed using phosphatidylcholine:phosphatidylserine proteoliposomes, in which the Ca2+ pump was activated by the negatively charged phospholipids (24). Regulation of the Ca(2+)-ATPase appeared to involve binding with the hydrophilic portion of phospholamban, as evidenced by cross-linking experiments, using a synthetic peptide that corresponded to amino acids 1-25 of phospholamban. These findings suggest that the fast-twitch isoform of the SR Ca(2+)-ATPase may be also regulated by phospholamban, although this regulator is not expressed in fast-twitch skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152030     DOI: 10.3109/09687689009025840

Source DB:  PubMed          Journal:  Membr Biochem        ISSN: 0149-046X


  5 in total

1.  Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum.

Authors:  P Sharma; V B Patchell; Y Gao; J S Evans; B A Levine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.

Authors:  G Hughes; A P Starling; R P Sharma; J M East; A G Lee
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

3.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

4.  The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca(2+)-ATPase.

Authors:  G Hughes; J M East; A G Lee
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

5.  Expression of phospholamban in C2C12 cells and regulation of endogenous SERCA1 activity.

Authors:  J M Harrer; S Ponniah; D G Ferguson; E G Kranias
Journal:  Mol Cell Biochem       Date:  1995-05-10       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.